BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16396993)

  • 1. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration.
    Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M
    FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice.
    Rolls A; Avidan H; Cahalon L; Schori H; Bakalash S; Litvak V; Lev S; Lider O; Schwartz M
    Eur J Neurosci; 2004 Oct; 20(8):1973-83. PubMed ID: 15450076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation.
    Rolls A; Shechter R; London A; Segev Y; Jacob-Hirsch J; Amariglio N; Rechavi G; Schwartz M
    PLoS Med; 2008 Aug; 5(8):e171. PubMed ID: 18715114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.
    Zhou J; Nagarkatti P; Zhong Y; Nagarkatti M
    J Neuroimmunol; 2010 Jun; 223(1-2):55-64. PubMed ID: 20434781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
    Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
    Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans.
    Egea J; García AG; Verges J; Montell E; López MG
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S24-7. PubMed ID: 20399898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.
    Hecht I; Hershkoviz R; Shivtiel S; Lapidot T; Cohen IR; Lider O; Cahalon L
    J Leukoc Biol; 2004 Jun; 75(6):1139-46. PubMed ID: 15020655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intraocular pressure in aged and immunocompromised rats.
    Bakalash S; Rolls A; Lider O; Schwartz M
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1181-90. PubMed ID: 17325162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
    Miyamoto K; Tanaka N; Moriguchi K; Ueno R; Kadomatsu K; Kitagawa H; Kusunoki S
    Glycobiology; 2014 May; 24(5):469-75. PubMed ID: 24584141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.
    Warford JR; Lamport AC; Clements DR; Malone A; Kennedy BE; Kim Y; Gujar SA; Hoskin DW; Easton AS
    Acta Neuropathol Commun; 2018 Jan; 6(1):4. PubMed ID: 29301568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
    Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis.
    Schluesener HJ; Seid K; Meyermann R
    Acta Neuropathol; 1999 Feb; 97(2):119-26. PubMed ID: 9928822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype.
    Ebert S; Schoeberl T; Walczak Y; Stoecker K; Stempfl T; Moehle C; Weber BH; Langmann T
    J Leukoc Biol; 2008 Sep; 84(3):736-40. PubMed ID: 18550791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
    Stanislaus R; Singh AK; Singh I
    J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
    Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.
    Sun D; Newman TA; Perry VH; Weller RO
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):374-84. PubMed ID: 15305983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.